Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bar-on

Showing results (541-550 of 556) with videos related to

Pageof 56
Sort By:
Transplantation and Cellular Therapy|July 2, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort StudyRon Ram, David Hagin, Nino Kikozashvilli, et al.
Cell Reports|January 24, 2024
Decidual-tissue-resident memory T cells protect against nonprimary human cytomegalovirus infection at the maternal-fetal interfaceOr Alfi, Mevaseret Cohen, Shikma Bar-On, et al.
Pediatric Pulmonology|October 23, 2025
Vaccine Coverage Among People With Cystic Fibrosis: A National Multicenter Cross-Sectional Study in IsraelLior Tsviban, Nofar Amitai, Hagit Levine, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 18, 2023
The new face of cystic fibrosis in the era of population genetic carrier screeningMiri Dotan, Hannah Blau, Amihood Singer, et al.
Frontiers in Molecular Neuroscience|September 19, 2024
A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's diseaseOfir Sade, Daphna Fischel, Noa Barak-Broner, et al.
Immunity|February 15, 2015
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attackChamutal Gur, Yara Ibrahim, Batya Isaacson, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 9, 2023
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effectsSuzy E Meijer, Ora Halutz, Amos Adler, et al.
JCI Insight|May 11, 2021
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.
Annals of Hematology|January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysisIrit Avivi, Chava Perry, Yafit Segman, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Pageof 56

Showing results (541-550 of 556) with videos related to

Sort By:
Pageof 56
Transplantation and Cellular Therapy|July 2, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort StudyRon Ram, David Hagin, Nino Kikozashvilli, et al.
Cell Reports|January 24, 2024
Decidual-tissue-resident memory T cells protect against nonprimary human cytomegalovirus infection at the maternal-fetal interfaceOr Alfi, Mevaseret Cohen, Shikma Bar-On, et al.
Pediatric Pulmonology|October 23, 2025
Vaccine Coverage Among People With Cystic Fibrosis: A National Multicenter Cross-Sectional Study in IsraelLior Tsviban, Nofar Amitai, Hagit Levine, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 18, 2023
The new face of cystic fibrosis in the era of population genetic carrier screeningMiri Dotan, Hannah Blau, Amihood Singer, et al.
Frontiers in Molecular Neuroscience|September 19, 2024
A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's diseaseOfir Sade, Daphna Fischel, Noa Barak-Broner, et al.
Immunity|February 15, 2015
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attackChamutal Gur, Yara Ibrahim, Batya Isaacson, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 9, 2023
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effectsSuzy E Meijer, Ora Halutz, Amos Adler, et al.
JCI Insight|May 11, 2021
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.
Annals of Hematology|January 27, 2022
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysisIrit Avivi, Chava Perry, Yafit Segman, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Pageof 56